Huixin Liang - Search Results

Year	Number of Results
2012	1
2013	1
2018	6
2019	7
2020	4
2021	9
2022	6
2023	8
2024	2

1

Targeting Mitochondria-Located circRNA SCAR Alleviates NASH via Reducing mROS Output.

Zhao Q, Liu J, Deng H, Ma R, Liao JY, Liang H, Hu J, Li J, Guo Z, Cai J, Xu X, Gao Z, Su S. Zhao Q, et al. Among authors: liang h. Cell. 2020 Oct 1;183(1):76-93.e22. doi: 10.1016/j.cell.2020.08.009. Epub 2020 Sep 14. Cell. 2020. PMID: 32931733 Free article.

2

Niche stiffness sustains cancer stemness via TAZ and NANOG phase separation.

Liu X, Ye Y, Zhu L, Xiao X, Zhou B, Gu Y, Si H, Liang H, Liu M, Li J, Jiang Q, Li J, Yu S, Ma R, Su S, Liao JY, Zhao Q. Liu X, et al. Among authors: liang h. Nat Commun. 2023 Jan 16;14(1):238. doi: 10.1038/s41467-023-35856-y. Nat Commun. 2023. PMID: 36646707 Free PMC article.

3

Tumor Cell-Intrinsic CD96 Mediates Chemoresistance and Cancer Stemness by Regulating Mitochondrial Fatty Acid β-Oxidation.

Li J, Xia Q, Di C, Li C, Si H, Zhou B, Yu S, Li Y, Huang J, Lu Y, Huang M, Liang H, Liu X, Zhao Q. Li J, et al. Among authors: liang h. Adv Sci (Weinh). 2023 Mar;10(7):e2202956. doi: 10.1002/advs.202202956. Epub 2022 Dec 29. Adv Sci (Weinh). 2023. PMID: 36581470 Free PMC article.

4

Additive manufacturing of bone scaffolds.

Yang Y, Wang G, Liang H, Gao C, Peng S, Shen L, Shuai C. Yang Y, et al. Among authors: liang h. Int J Bioprint. 2018 Dec 12;5(1):148. doi: 10.18063/IJB.v5i1.148. eCollection 2019. Int J Bioprint. 2018. PMID: 32596528 Free PMC article. Review.

5

Fibroblast growth factor 21: A "rheostat" for metabolic regulation?

She QY, Bao JF, Wang HZ, Liang H, Huang W, Wu J, Zhong Y, Ling H, Li A, Qin SL. She QY, et al. Among authors: liang h. Metabolism. 2022 May;130:155166. doi: 10.1016/j.metabol.2022.155166. Epub 2022 Feb 18. Metabolism. 2022. PMID: 35183545 Review.

6

Mitochondrial noncoding RNAs: new wine in an old bottle.

Liang H, Liu J, Su S, Zhao Q. Liang H, et al. RNA Biol. 2021 Dec;18(12):2168-2182. doi: 10.1080/15476286.2021.1935572. Epub 2021 Jun 10. RNA Biol. 2021. PMID: 34110970 Free PMC article. Review.

7

PROTAC derivatization of natural products for target identification and drug discovery: Design of evodiamine-based PROTACs as novel REXO4 degraders.

Chen S, Bi K, Liang H, Wu Z, Huang M, Chen X, Dong G, Sheng C. Chen S, et al. Among authors: liang h. J Adv Res. 2023 Oct 31:S2090-1232(23)00318-1. doi: 10.1016/j.jare.2023.10.014. Online ahead of print. J Adv Res. 2023. PMID: 37913903 Free article.

8

Discovery of novel bis-evodiamine derivatives with potent antitumor activity.

Liang H, Wang W, Zhu F, Chen S, Liu D, Sheng C. Liang H, et al. Bioorg Med Chem. 2022 Jul 1;65:116793. doi: 10.1016/j.bmc.2022.116793. Epub 2022 May 6. Bioorg Med Chem. 2022. PMID: 35550978

9

Design, Synthesis, and Structure-Activity relationships of Evodiamine-Based topoisomerase (Top)/Histone deacetylase (HDAC) dual inhibitors.

Zhu F, Meng X, Liang H, Sheng C, Dong G, Liu D, Wu S. Zhu F, et al. Among authors: liang h. Bioorg Chem. 2022 May;122:105702. doi: 10.1016/j.bioorg.2022.105702. Epub 2022 Mar 6. Bioorg Chem. 2022. PMID: 35286923

10

Zn-doped chitosan/alginate multilayer coatings on porous hydroxyapatite scaffold with osteogenic and antibacterial properties.

He Z, Jiao C, Wu J, Gu J, Liang H, Shen L, Yang Y, Tian Z, Wang C, Jiang Q. He Z, et al. Among authors: liang h. Int J Bioprint. 2023 Jan 13;9(2):668. doi: 10.18063/ijb.v9i2.668. eCollection 2023. Int J Bioprint. 2023. PMID: 37065667 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

38 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year